Tag:
EMA
Internal Medicine
Finerenone, a Mineralocorticoid Receptor Blocker Against Heart Failure
The European Medicines Agency (EMA) has authorized the use of the mineralocorticoid drug Kerendia (finerenone) for the treatment of heart failure. Initially, the drug...